LeapFinancial | $3,500,000 | (Dec 20, 2024)
TG0 | $5,619,170 | (Dec 20, 2024)
Mindgard | $8,000,000 | (Dec 20, 2024)
Vivoo
United States
- San Francisco, California
- 02/11/2021
- Series A
- $6,000,000
Vivoo is a wellness-tech innovation company that develops, improves, and offers personalized products using state-of-the-art technology.
The company has developed an at-home urine test & mobile application that helps users boost their wellness.
Meet Vivoo:
*Real-Time Body Data: Vitamin C, Magnesium, Calcium, Water, Ketone, Sodium, pH, Oxidative Stress, and Protein through an at-home urine test
*5,000 Personalized Advice: Users can get personalized nutritional & lifestyle advice prepared by dietitians, nutritionists, and doctors
*Wearable Integration: Wearable data can be integrated to the App to get insight on Activity, Sleep, and Heart Rate
*Personalized Supplements: Users can order personalized supplements based on Vivoo test results
*300+ Wellness Articles: Articles on trendy wellness topics can be accessed through the App
Vivoo's mission is to make body data more accessible and understandable for all consumers worldwide, empowering them to live better lives.
The company has been backed by Draper Associates, ONCE Ventures, Revo Capital, 500 Startups, Halogen Ventures and Techstars.
- Industry Wellness and Fitness Services
- Website https://vivoo.io/
- LinkedIn https://www.linkedin.com/company/vivoo/
ŌURA | $200,000,000 | (Dec 20, 2024)
Buildpeer | $2,500,000 | (Dec 20, 2024)
Embeddable | $6,238,050 | (Dec 20, 2024)
Tenor | $5,400,000 | (Dec 20, 2024)
SOTELIX Endoscopy | $1,700,000 | (Dec 20, 2024)
Double(US) | $3,900,000 | (Dec 20, 2024)
Hauler Hero | $10,000,000 | (Dec 20, 2024)
TripSuite | $5,000,000 | (Dec 20, 2024)
Seekho | $8,000,000 | (Dec 19, 2024)